Antihyperglycemic action of rhodiola-aqeous extract in type1-like diabetic rats

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Niu, Chiang Shan ^a   Chen, Li Jen ^b   Niu, Ho Shan ^a  

^a TZU CHI COLLEGE OF TECHNOLOGY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Adrenalectomy; Hyperglycemia; Opioid receptor; Plasma glucose; Rhodiola water extract

Indexed keywords

BETA ENDORPHIN; CYPRODIME; GLUCOSE; GLUCOSE OXIDASE; GLUCOSE TRANSPORTER 4; MESSENGER RNA; MU OPIATE RECEPTOR; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RHODIOLA ROSEA EXTRACT; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; PHOSPHOENOLPYRUVATE CARBOXYKINASE 1 (SOLUBLE) PROTEIN, RAT; PLANT EXTRACT; SIGNAL PEPTIDE; SLC2A4 PROTEIN, RAT; WATER;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; IMMUNOREACTIVITY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WESTERN BLOTTING; ADRENAL GLAND; ANALYSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; ENZYMOLOGY; HYPERGLYCEMIA; LIVER; METABOLISM; RHODIOLA; SECRETION (PROCESS); WISTAR RAT;

ADRENAL GLANDS; ANIMALS; BETA-ENDORPHIN; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE TRANSPORTER TYPE 4; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MALE; MUSCLE, SKELETAL; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PLANT EXTRACTS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; RHODIOLA; RNA, MESSENGER; WATER;

EID: 84892416038     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-20     Document Type: Article

References (60)

1. Nanchen D, Rodondi N, Cornuz J, Hillier T, Ensrud KE, Cauley JA, Bauer DC. Mortality associated with diabetes and cardiovascular disease in older women. PLoS One 2012, 7:e48818. 10.1371/journal.pone.0048818, 3492230, 23144985.
2. Kumar B, Gupta SK, Saxena R, Srivastava S. Current trends in the pharmacotherapy of diabetic retinopathy. J Postgrad Med 2012, 58:132-139.
3. Brosius FC, Alpers CE. New targets for treatment of diabetic nephropathy: what we have learned from animal models. Curr Opin Nephrol Hypertens 2013, 22:17-25. 3776427, 23207723.
4. Kan M, Guo G, Singh B, Singh V, Zochodne DW. Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy. J Neuropathol Exp Neurol 2012, 71:494-510. 10.1097/NEN.0b013e3182580673, 22588388.
5. Haak T. Initial combination with linagliptin and metformin in newly diagnosed type 2 diabetes and severe hyperglycemia. Adv Ther 2012, 29(12):1005-1015. doi: 10.1007/s12325-012-0066-0. Epub 2012 Nov 29, 10.1007/s12325-012-0066-0, 23212658.
6. Pugliese A. The multiple origins of type 1 diabetes. Diabet Med 2012, doi:10.1038/ng1708.
7. Hamdy O, Goodyear LJ, Horton ES. Diet and exercise in type 2 diabetes mellitus. Endocrinol Metab Clin North Am 2001, 30:883-907. 10.1016/S0889-8529(05)70220-6, 11727404.
8. Onat A. Metabolic syndrome: nature, therapeutic solutions and options. Expert Opin Pharmacother 2011, 12:1887-1900. 10.1517/14656566.2011.585462, 21756201.
9. Vinik AI, Cincotta AH, Scranton RE, Bohannon N, Ezrokhi M, Gaziano JM. Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agents. Endocr Pract 2012, 18(6):931-943. doi: 10.4158/EP12187.OR, 10.4158/EP12187.OR, 23186965.
10. Yoo KM, Lee C, Lo YM, Moon B. The hypoglycemic effects of American red ginseng (Panax quinquefolius L.) on a diabetic mouse model. J Food Sci 2012, 77:H147-H152. 10.1111/j.1750-3841.2012.02748.x, 22757707.
11. Pinto Mda S, Ranilla LG, Apostolidis E, Lajolo FM, Genovese MI, Shetty K. Evaluation of antihyperglycemia and antihypertension potential of native Peruvian fruits using in vitro models. J Med Food 2009, 12:278-291. 10.1089/jmf.2008.0113, 19459727.
12. Chan SW. Panax ginseng, Rhodiola rosea and Schisandra chinensis. Int J Food Sci Nutr 2012, 63(1):75-81.
13. Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 2010, 17:481-493. 10.1016/j.phymed.2010.02.002, 20378318.
14. Wiedenfeld H, Dumaa M, Malinowski M, Furmanowa M, Narantuya S. Phytochemical and analytical studies of extracts from Rhodiola rosea and Rhodiola quadrifida. Pharmazie 2007, 62:308-311.
15. Lee WJ, Chung HH, Cheng YZ, Lin HJ, Cheng JT. Rhodiola-water extract induces beta-endorphin secretion to lower blood pressure in spontaneously hypertensive rats. Phytother Res 2012, doi: 10.1002/ptr.4900.
16. Liu IM, Cheng JT. Mediation of endogenous beta-endorphin in the plasma glucose-lowering action of herbal products observed in type 1-like diabetic rats. Evid Based Complement Altern Med 2011, 2011:987876.
17. Su CH, Liu IM, Chung HH, Cheng JT. Activation of I2-imidazoline receptors by agmatine improved insulin sensitivity through two mechanisms in type-2 diabetic rats. Neurosci Lett 2009, 457:125-128. 10.1016/j.neulet.2009.03.093, 19429177.
18. Liu IM, Chi TC, Chen YC, Lu FH, Cheng JT. Activation of opioid mu-receptor by loperamide to lower plasma glucose in streptozotocin-induced diabetic rats. Neurosci Lett 1999, 265:183-186. 10.1016/S0304-3940(99)00226-8, 10327161.
19. Cheng JT, Liu IM, Chi TC, Tzeng TF, Lu FH, Chang CJ. Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes 2001, 50:2815-2821. 10.2337/diabetes.50.12.2815, 11723065.
20. Cheng JT, Liu IM, Tzeng TF, Tsai CC, Lai TY. Plasma glucose-lowering effect of beta-endorphin in streptozotocin-induced diabetic rats. Horm Metab Res 2002, 34:570-576. 10.1055/s-2002-35418, 12439785.
21. Ming DS, Hillhouse BJ, Guns ES, Eberding A, Xie S, Vimalanathan S, Towers GH. Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother Res 2005, 19:740-743. 10.1002/ptr.1597, 16220564.
22. Guo N, Hu Z, Fan X, Zheng J, Zhang D, Xu T, Yu T, Wang Y, Li H. Simultaneous determination of salidroside and its aglycone metabolite p-tyrosol in rat plasma by liquid chromatography-tandem mass spectrometry. Molecules 2012, 17:4733-4754. 10.3390/molecules17044733, 22525439.
23. Liu IM, Chen WC, Cheng JT. Mediation of beta-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 2003, 307:1196-1204. 10.1124/jpet.103.053900, 12975496.
24. Luippold G, Klein T, Mark M, Grempler R. Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus. Diabetes Obes Metab 2012, 14:601-607. 10.1111/j.1463-1326.2012.01569.x, 22268612.
25. Moreira-Rodrigues M, Quelhas-Santos J, Serrao P, Fernandes-Cerqueira C, Sampaio-Maia B, Pestana M. Glycaemic control with insulin prevents the reduced renal dopamine D1 receptor expression and function in streptozotocin-induced diabetes. Nephrol Dial Transplant 2010, 25:2945-2953. 10.1093/ndt/gfq150, 20339101.
26. Yu BC, Chang CK, Su CF, Cheng JT. Mediation of beta-endorphin in andrographolide-induced plasma glucose-lowering action in type I diabetes-like animals. Naunyn Schmiedebergs Arch Pharmacol 2008, 377:529-540. 10.1007/s00210-007-0240-0, 18080810.
27. Niu HS, Hsu FL, Liu IM, Cheng JT. Increase of beta-endorphin secretion by syringin, an active principle of eleutherococcus senticosus, to produce antihyperglycemic action in type 1-like diabetic rats. Horm Metab Res 2007, 39:894-898. 10.1055/s-2007-993154, 18075969.
28. Hwang SL, Liu IM, Tzeng TF, Cheng JT. Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats. Diabetologia 2005, 48:767-775. 10.1007/s00125-005-1698-2, 15756537.
29. Chan P, Wong KL, Liu IM, Tzeng TF, Yang TL, Cheng JT. Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats. J Hypertens 2003, 21:761-769. 10.1097/00004872-200304000-00020, 12658023.
30. Cheng JT, Liu IM, Chi TC, Tzeng TF. Release of beta-endorphin by prostaglandin E2 to lower plasma glucose in streptozotocin-induced diabetic rats. Horm Metab Res 2001, 33:439-443. 10.1055/s-2001-16236, 11507683.
31. Huang CH, Chen MF, Chung HH, Cheng JT. Antihyperglycemic effect of syringaldehyde in streptozotocin-induced diabetic rats. J Nat Prod 2012, 75:1465-1468. 10.1021/np3003723, 22880723.
32. Johansen O, Vaaler S, Jorde R, Reikeras O. Increased plasma glucose levels after hypnorm anaesthesia, but not after pentobarbital anaesthesia in rats. Lab Anim 1994, 28:244-248. 10.1258/002367794780681723, 7967463.
33. Biswas M, Kar B, Bhattacharya S, Kumar RB, Ghosh AK, Haldar PK. Antihyperglycemic activity and antioxidant role of terminalia arjuna leaf in streptozotocin-induced diabetic rats. Pharm Biol 2011, 49:335-340. 10.3109/13880209.2010.516755, 21281245.
34. Zeng L, Wan L, Chen L, Li S, Lu Y, Huang Q, Wang L, Li Y, Cheng J, Lu X. Selective depletion of activated T cells by recombinant immunotoxin containing anti-CTLA-4 single-chain fragment of variable antibody and N-terminal fragment of perforin. Transplant Proc 2006, 38:2151-2153. 10.1016/j.transproceed.2006.06.045, 16980028.
35. Niu HS, Hsu FL, Liu IM, Cheng JT. Increase of beta-endorphin secretion by syringin, an active principle of eleutherococcus senticosus, to produce antihyperglycemic action in type 1-like diabetic rats. Horm Metab Res 2007, 39:894-898. 10.1055/s-2007-993154, 18075969.
36. Evans AA, Khan S, Smith ME. Evidence for a hormonal action of beta-endorphin to increase glucose uptake in resting and contracting skeletal muscle. J Endocrinol 1997, 155:387-392. 10.1677/joe.0.1550387, 9415073.
37. Evans AA, Tunnicliffe G, Knights P, Bailey CJ, Smith ME. Delta opioid receptors mediate glucose uptake in skeletal muscles of lean and obese-diabetic (ob/ob) mice. Metabolism 2001, 50:1402-1408. 10.1053/meta.2001.28158, 11735084.
38. Hughes S, Smith ME, Bailey CJ. Beta-endorphin and corticotropin immunoreactivity and specific binding in the neuromuscular system of obese-diabetic mice. Neuroscience 1992, 48:463-468. 10.1016/0306-4522(92)90505-V, 1318515.
39. Hughes S, Smith ME, Bailey CJ. POMC-derived peptides in the neuromuscular system of streptozotocin-diabetic mice. Peptides 1992, 13:873-877. 10.1016/0196-9781(92)90043-3, 1336186.
40. Cheng JT, Liu IM, Chi TC, Tzeng TF. Increase of opioid mu-receptor gene expression in streptozotocin-induced diabetic rats. Horm Metab Res 2001, 33:467-471. 10.1055/s-2001-16939, 11544560.
41. Cheng JT, Huang CC, Liu IM, Tzeng TF, Chang CJ. Novel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic rats. Diabetes 2006, 55:819-825. 10.2337/diabetes.55.03.06.db05-0934, 16505249.
42. Tzeng TF, Liou SS, Chang CJ, Liu IM. The ethanol extract of zingiber zerumbet attenuates streptozotocin-induced diabetic nephropathy in rats. Evid Based Complement Altern Med 2013, 2013:340645.
43. Chen ZC, Shieh JP, Chung HH, Hung CH, Lin HJ, Cheng JT. Activation of peripheral opioid micro-receptors in blood vessel may lower blood pressure in spontaneously hypertensive rats. Pharmacology 2011, 87:257-264. 10.1159/000326084, 21494057.
44. Lee LM, Lin CS, Chung HH, Lin KC, Cheng JT. Urinary bladder relaxation through activation of opioid mu-receptors induced by loperamide is increased in diabetic rats. Exp Clin Endocrinol Diabetes 2012, 120:323-328.
45. Niu CS, Chen W, Wu HT, Cheng KC, Wen YJ, Lin KC, Cheng JT. Decrease of plasma glucose by allantoin, an active principle of yam (Dioscorea spp.), in streptozotocin-induced diabetic rats. J Agric Food Chem 2010, 58:12031-12035. 10.1021/jf103234d, 21043501.
46. Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F. Beta-endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. Science 1977, 197:1367-1369. 10.1126/science.197601, 197601.
47. Lai DM, Tu YK, Liu IM, Chen PF, Cheng JT. Mediation of beta-endorphin by ginsenoside Rh2 to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med 2006, 72:9-13. 10.1055/s-2005-916177, 16450289.
48. Liu IM, Liou SS, Cheng JT. Mediation of beta-endorphin by myricetin to lower plasma glucose in streptozotocin-induced diabetic rats. J Ethnopharmacol 2006, 104:199-206. 10.1016/j.jep.2005.09.001, 16203117.
49. Consoli A, Nurjhan N, Capani F, Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 1989, 38:550-557. 10.2337/diab.38.5.550, 2653926.
50. Wi JK, Kim JK, Youn JH. Mechanisms of postabsorptive hyperglycemia in streptozotocin diabetic rats. Am J Physiol 1996, 270:E752-E758.
51. Gomez-Valades AG, Vidal-Alabro A, Molas M, Boada J, Bermudez J, Bartrons R, Perales JC. Overcoming diabetes-induced hyperglycemia through inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP) with RNAi. Mol Ther 2006, 13:401-410. 10.1016/j.ymthe.2005.08.026, 16271515.
52. Leto D, Saltiel AR. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 2012, 13:383-396. 10.1038/nrm3351, 22617471.
53. Shieh JP, Cheng KC, Chung HH, Kerh YF, Yeh CH, Cheng JT. Plasma glucose lowering mechanisms of catalpol, an active principle from roots of Rehmannia glutinosa, in streptozotocin-induced diabetic rats. J Agric Food Chem 2011, 59:3747-3753. 10.1021/jf200069t, 21391677.
54. Seatter MJ, Gould GW. The mammalian facilitative glucose transporter (GLUT) family. Pharm Biotechnol 1999, 12:201-228.
55. Pessin JE, Bell GI. Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu Rev Physiol 1992, 54:911-930. 10.1146/annurev.ph.54.030192.004403, 1562197.
56. Cheng JT, Liu IM, Tzeng TF, Tsai CC, Lai TY. Plasma glucose-lowering effect of beta-endorphin in streptozotocin-induced diabetic rats. Horm Metab Res 2002, 34:570-576. 10.1055/s-2002-35418, 12439785.
57. Kai Y, Matsumura H, Izui K. Phosphoenolpyruvate carboxylase: three-dimensional structure and molecular mechanisms. Arch Biochem Biophys 2003, 414:170-179. 10.1016/S0003-9861(03)00170-X, 12781768.
58. Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 2010, 17:481-493. 10.1016/j.phymed.2010.02.002, 20378318.
59. Peschel W, Prieto JM, Karkour C, Williamson EM. Effect of provenance, plant part and processing on extract profiles from cultivated European Rhodiola rosea L. for medicinal use. Phytochemistry 2013, 86:92-102.
60. Wang J, Rong X, Li W, Yang Y, Yamahara J, Li Y. Rhodiola crenulata root ameliorates derangements of glucose and lipid metabolism in a rat model of the metabolic syndrome and type 2 diabetes. J Ethnopharmacol 2012, 142:782-788. 10.1016/j.jep.2012.05.063, 22683493.